.Following a bad revealing for Lykos Therapies' MDMA applicant for trauma at a recent FDA consultato...
.AN2 Rehabs is actually reviewing its company in action to dull midphase data, swearing to give up h...
.Merck & Co. is paying out $700 million beforehand to challenge Amgen in a blood cancer market. T...
.Along With Gilead Sciences on the verge of an FDA decision for its own liver disease drug seladelpa...
.CEO David Ricks can easily observe the firms putting together camping tents at basecamp behind Eli ...
.Bed Liquidators has switched Entero Therapeutics white as a piece. The lender ordered Entero to rep...
.Exelixis is quiting on its tissue aspect (TF)- targeting antibody-drug conjugate after concluding t...
.Three weeks after Roche's Genentech unit bowed out an SHP2 prevention treaty, Relay Therapy has act...
.Stoke Therapeutics' Dravet disorder drug has actually been actually devoid of a partial grip, remov...
.Tough Biotech Partner Editor Gabrielle Masson showed the 2024 lesson of Intense 15 victors on the f...